![Madhu Cherukury](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Madhu Cherukury
Vorstandsvorsitzender bei Allgenesis Biotherapeutics, Inc.
Aktive Positionen von Madhu Cherukury
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Allgenesis Biotherapeutics, Inc.
![]() Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 01.06.2018 | - |
Karriereverlauf von Madhu Cherukury
Statistik
International
Taiwan | 2 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Allgenesis Biotherapeutics, Inc.
![]() Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Health Technology |
- Börse
- Insiders
- Madhu Cherukury
- Erfahrung